Dr Vikash Prakash

Dr. Vikash Prakash is a highly skilled gastroenterologist and hepatology specialist with extensive experience in advanced liver and gastrointestinal care. He is known for his precision in diagnosis, evidence-based treatment strategies, and expertise in complex endoscopic procedures. His clinical approach focuses on personalised care for chronic liver diseases and gastrointestinal conditions. Dr. Prakash is actively involved in academic research and medical advancements in hepatology.

Educational Qualification:

• MBBS – Vardhman Mahavir Medical College, New Delhi
• MD (General Medicine) – Dr. Ram Manohar Lohia Hospital & Post Graduate Institute of Medical Education and Research, New Delhi
• DM (Hepatology) – Institute of Liver and Biliary Sciences, New Delhi

Professional Experience:

• Over 15 years of medical experience, including 9 years of specialised practice in gastroenterology and hepatology.
• Expertise in advanced diagnostic and therapeutic gastrointestinal procedures such as Endoscopy, Colonoscopy, Capsule Endoscopy, ERCP, Stenting, and Dilation.
• Specialised in hepatic venous pressure gradient (HVPG) measurement for portal hypertension management.
• Extensive experience in managing liver cirrhosis, SBP, pancreatitis, cholangitis, and cholecystitis.

Awards and Achievements:

• Award for Academic Excellence in Doctorate of Medicine (DM).
• ‘International Young Investigator Travel Award’ – AASLD, Boston.
• ‘Young Investigator Award’ – AASLD, Washington, DC.
• First Prize, National Conference Hepatology Quiz, New Delhi.
• Award for Case Presentation, Delhi.

Professional Membership:

• Member, American Association for the Study of Liver Diseases (AASLD)

Publications:

• Hepatology Communications (2022 Jun); 6(6): 1289–1300. doi: 10.1002/hep4.1904. PMID: 35037744.
• Liver International (2023 Jun); 43(6): 1298–1306. doi: 10.1111/liv.15534. PMID: 36748109.
• Oral presentation at AASLD, Boston (2016): “A randomized study to compare the efficacy of carbapenem versus carbapenem plus GM-CSF in difficult-to-treat spontaneous bacterial peritonitis.”
• Oral presentation at AASLD, Washington, DC (2017): “A prospective study assessing the efficacy and safety of early introduction of low-dose terlipressin in addition to noradrenaline as a vasopressor in patients with cirrhosis and septic shock.”